李敏,杨琳,常翔,倪炯臣,李思诗,张雷雷,刘翠
LI Min,YANG Lin,CHANG Xiang,NI Jiongchen,LI Sishi,ZHANG Leilei,LIU Cui

• 1:西安市中医医院脑病科
• 2:陕西中医药大学

摘要(Abstract)：

目的：探讨苓桂术甘汤合泽泻汤对痰饮型耳石症复位后残余头晕及复发的作用。方法：将144例痰饮型耳石症复位后残余头晕患者按随机数字表分为A组、B组、C组和D组，4组均服用甲磺酸倍他司汀片，B组、C组、D组分别予以苓桂术甘汤、泽泻汤、苓桂术甘汤合泽泻汤治疗，均治疗3周。比较4组治疗前后头晕症状、总有效率、前庭症状指数（VSI）、Berg平衡量表（BBS）评分、不良反应；统计耳石症复发率。结果：治疗前4组眩晕障碍量表（DHI）各维度评分和总分差异无统计学意义（P>0.05），治疗后4组DHI各维度评分和总分均低于治疗前（P<0.05），且治疗后D组DHI各维度评分和总分均低于其余3组，B组和C组均低于A组（P<0.05）;4组总有效率差异有统计学意义（P<0.05）,D组总有效率高于A组（P<0.01）；治疗后4组VSI评分均下降（P<0.05），且D组低于其余3组（P<0.05）,B组、C组低于A组（P<0.05）；治疗后4组BBS评分均升高（P<0.05），且D组高于其余3组（P<0.05）,B组、C组高于A组（P<0.05）;4组不良反应发生率比较，差异无统计学意义（P>0.05）,D组随访6个月内耳石症复发率低于A组（P<0.01）。结论：对痰饮型耳石症复位后残余头晕患者在甲磺酸倍他司汀片的基础上采用苓桂术甘汤、泽泻汤治疗均可减轻症状，疗效确切、安全，且均能够减轻前庭症状、提升评分能力，二者合用效果更佳，且安全可靠，降低耳石症复发率。
Objective:To explore the effect of Linggui Zhugan Decoction（苓桂术甘汤） combined with Zexie Decoction（泽泻汤） on residual dizziness and dizziness relapse of phlegm and retained fluid type after canalith repositioning procedure(CRP). Methods :Totally,144 patients with residual dizziness of phlegm and retained fluid type after CRP were randomly divided into group A,group B,group C and group D. All groups were treated with betahistine mesylate tablets. Besides,group B,group C and group D were treated with Linggui Zhugan Decoction,Zexie Decoction,Linggui Zhugan Decoction combined with Zexie Decoction,respectively,for 3 weeks. Dizziness symptoms before and after treatment,total effective rates,changes of Vestibular Symptom Index(VSI) and Berg Balance Scale(BBS) scores before and after treatment and adverse reactions were compared among the 4 groups. The relapse rate of canalith were compared. Results:Before treatment,there were no significant differences in the scores of every dimension and total scores of vertigo disorder scale(DHI) among the 4 groups(P>0.05). After treatment,the scores of every dimension and total scores of DHI in the 4 groups were lower than those before treatment(P<0.05),and in group D were lower than those in the other 3 groups(P<0.05),and the scores in group B and group C were lower than those in group A(P<0.05). There was a significant difference in the total effective rates among the 4 groups(P<0.05),and the total effective rate of group D was higher than that of group A(P<0.01). The VSI score in the 4groups after treatment decreased(P<0.05),and in group D was lower than that in the other 3 groups(P<0.05),and the score in group B and group C was lower than that in group A(P<0.05). The BBS score in the 4 groups after treatment increased(P<0.05),and in group D was higher than that in the other 3 groups(P<0.05),and the score in group B and group C was higher than that in group A(P<0.05). There was no significant difference in the incidences of adverse reactions among the 4 groups(P>0.05),and the relapse rate of canalith in group D within 6 months of following-up was lower than that in group A(P<0.01). Conclusions:Linggui Zhugan Decoction and Zexie Decoction are both effective and safe in the treatment of residual dizziness of phlegm and retained fluid type after CRP besides treated with betahistine mesylate. These two treatments are safe and reliable,and both can reduce vestibular symptoms and improve scores. The combination of both decoction is of better effect,and is safe and reliable. It can reduce the relapse rate of canalith.

关键词(KeyWords)： 苓桂术甘汤;泽泻汤;痰饮型耳石症;残余头晕;复发
Linggui Zhugan Decoction;Zexie Decoction;canalith of phlegm and retained fluid type;residual dizziness;relapse

Abstract:

Keywords:

基金项目(Foundation): 陕西省重点研发计划项目（编号：2018BAI08B04）;; 西安市中医药科研项目（编号：201881）;; 国家重点研发计划项目（编号：2018YFC1707204）

作者(Author): 李敏,杨琳,常翔,倪炯臣,李思诗,张雷雷,刘翠
LI Min,YANG Lin,CHANG Xiang,NI Jiongchen,LI Sishi,ZHANG Leilei,LIU Cui

DOI: 10.16295/j.cnki.0257-358x.2023.04.009

参考文献(References)：

• [1]MUMFORD C J.Post-traumatic benign paroxysmal positional vertigo[J].Pract Neurol,2019,19(4):354-355.
• [2]MANDALàM,SALERNI L,NUTI D.Benign positional paroxysmal Vertigo treatment:a practical update[J].Curr Treat Options Neurol,2019,21(12):66.
• [3]徐磊，李晓炎，邱培森，等.104例良性阵发性位置性眩晕诊治体会[J].中国实验诊断学，2019,23(3):494-496.
• [4]SCHOLTZ A W,HAHN A,STEFFLOVA B,et al.Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride16 mg in patients with peripheral vestibular vertigo:a prospective,multinational,multicenter,double-blind,randomized,non-inferiority clinical trial[J].Clin Drug Investig,2019,39(11):1045-1056.
• [5]ASADI P,ZIA ZIABARI S M,MAJDI A,et al.Cinnarizine/betahistine combination vs.the respective monotherapies in acute peripheral vertigo:a randomized triple-blind placebo-controlled trial[J].Eur J Clin Pharmacol,2019,75(11):1513-1519.
• [6]高强，张天琪，刘岑，等.化湿通窍方治疗良性阵发性位置性眩晕复位后残余症状的临床观察[J].现代中医临床，2019,26(4):17-20.
• [7]郭进财，涂燕芬，颜光华，等.耳石复位法配合苓桂术甘汤合泽泻汤治疗良性阵发性位置性眩晕疗效初探[J].中国中医急症，2013,22(9):1544-1545.
• [8]吴子明，蒋子栋.头晕与眩晕诊疗攻略[M].北京：中国协和医科大学出版社，2016:212-215.
• [9]陈园桃.中医病证诊疗常规[M].南京：东南大学出版社，2008:162-168.
• [10]修世国，邢东升，胡玮，等.眩晕障碍量表在BPPV患者生活质量评估中的应用[J].听力学及言语疾病杂志，2014,22(1):48-52.
• [11]韩炳仁，林埈成，金知秀，等.眩晕与耳鸣：图解眩晕与耳鸣的诊治实战处方[M].钟利群，唐先平，译.北京：中国纺织出版社，2015:125-127.
• [12]王密.眩晕与平衡障碍的前庭康复治疗[D].郑州：郑州大学，2015.
• [13]金冬梅，燕铁斌.Berg平衡量表及其临床应用[J].中国康复理论与实践，2002,8(3):155-157.
• [14]ADEGBIJI W A,OLAJIDE T G,OLUBI O,et al.Clinicoepidemiology of benign paroxysmal positional vertigo in Nigerian[J].J Family Med Prim Care,2019,8(10):3220-3224.
• [15]WU P,CAO W,HU Y,et al.Effects of vestibular rehabilitation,with or without betahistine,on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo:a protocol for a randomised controlled trial[J].BMJ Open,2019,9(6):e026711.
• [16]李虹，李翠贤，朱官印.针刺治疗中老年耳石症复位后残余头晕30例临床研究[J].江苏中医药，2019,51(4):60-62.
• [17]马晓依，王月，肖钰雪.茯苓饮加减治疗良性阵发性位置性眩晕手法复位后残余头晕[J].吉林中医药，2019,39(10):1301-1303,1309.
• [18]谢风帆，张玉琴，赖文芳，等.栝楼桂枝汤通过抑制小胶质细胞活化改善大鼠脑缺血/再灌注损伤[J].中国药理学通报，2020,36(5):703-709.
• [19]李佳欣，陈思琦，吴鑫宇，等.泽泻现代药理学研究[J].辽宁中医药大学学报，2020,22(2):143-146.
• [20]罗炽琼，李倩，张琦.苓桂术甘汤合泽泻汤对膜迷路积水豚鼠前庭膜AQP2表达的影响[J].中华中医药杂志，2015,30(2):578-580.